May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
The Effect of Topical Hypotensive Lipids on Macular Thickness Following Cataract Extraction
Author Affiliations & Notes
  • B.A. Hughes
    Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • S. Muenk
    Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • J.S. Bryant
    Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • M.Y. Alexander
    Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • M.E. Citron
    Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI
  • Footnotes
    Commercial Relationships  B.A. Hughes, Alcon, Allergan, & Merck, R; S. Muenk, None; J.S. Bryant, None; M.Y. Alexander, Allergan, R; M.E. Citron, None.
  • Footnotes
    Support  RPB
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 459. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.A. Hughes, S. Muenk, J.S. Bryant, M.Y. Alexander, M.E. Citron; The Effect of Topical Hypotensive Lipids on Macular Thickness Following Cataract Extraction . Invest. Ophthalmol. Vis. Sci. 2006;47(13):459.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the effect of topical hypotensive lipids on macular thickness following cataract surgery in patients with glaucoma, measured using Optical Coherence Tomography (OCT).

Methods: : This prospective study measures macular thickness in patients before and after cataract extraction by phacoemulsification with and without the use of topical hypotensive lipids. Macular thickness was measured using OCT before and after surgery in patients using topical hypotensive lipids and patients not on topical therapy. All patients had similar post operative treatment of topical steroid and antibiotic ointment. Patients with pre–existing macular disease were excluded. OCT measurement calculations used for analysis included fovea, the average of four quadrants of the inner ring of macular measurement, and similarly for the outer macular ring, as provided by OCT software.

Results: : Twelve glaucoma patients using topical hypotensive lipids and 22 patients not on topical therapy underwent cataract extraction. The average age was 75.5 ± 5.4 years in patients receiving topical therapy and 75.8 ± 7.7 in patients not on topical therapy. Inner macular thickness was 241.5 ± 20.9 microns prior to and 254.6 ± 30.8 microns following cataract extraction in the treatment group and 241.3 ± 26.3 microns prior to and 257.9 ± 23.7 microns after in the control group. Outer macular thickness was 215.6 ± 17.0 microns prior to and 219.5 ± 24.7 microns following cataract extraction in the treatment group and 214.9 ± 16.6 microns prior to and 225.3 ± 19.4 microns after in the control group There was no difference in change in inner (13.1 vs. 16.6 microns) or outer (3.9 vs.10.4 microns) macular thickness between the treatment and control groups (P = 0.6, and 0.2, respectively).

Conclusions: : Perioperative use of topical hypotensive medications have no effect on macular thickness after cataract extraction, compared to control, if intraocular pressure control is necessary.

Keywords: treatment outcomes of cataract surgery • drug toxicity/drug effects • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×